rituximab – Page 8 – Communicable Diseases Research

Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study

COVID-19 백신 접종 후 항-CD20 치료 환자의 강력한 T-세포 반응: 전향적 코호트 연구

Observational Study

Published on 2022-08-242022-09-11
Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 임상, 진단, 치료기술,

Detection of viable SARS-CoV-2 in deep respiratory specimens despite negative nasopharyngeal SARS-CoV-2 RT-PCR: occult COVID-19 as an unsuspected cause of pulmonary infiltrates in immunocompromised patients

Case report

Published on 2022-08-232022-10-05
Journal: IDCases [Category] 진단, 치료기술,

[키워드] anti-CD20 Antigen Antiviral treatment BAL Bronchoalveolar lavage changes clearance COVID-19 COVID-19 infection demonstrated detection diagnosed Diagnosis etiology highlight Immunocompromise Immunocompromised patient Immunocompromised patients immunohistochemistry invasive Isolation limit lung lung parenchyma lung tissue nasopharyngeal occult Occult COVID-19 pandemic parenchymal Patient persistence Precaution Primary infection Prolonged pulmonary infiltrate Relapse repeated Replication reported resolved respiratory specimen rituximab SARS-CoV-2 SARS-CoV-2 nucleocapsid SARS-CoV-2 virus specimens spike-protein suggested Viral antigen viral persistence virus
[DOI] 10.1016/j.idcr.2022.e01611 [Article Type] Case report

Hepatitis B Surface Antibody (Anti-HBs) Kinetics during Rituximab Chemotherapy and Performance of Hepatitis B Vaccine before Immunosuppression: Two Prospective Studies

Article

Published on 2022-08-152023-06-13
Journal: Viruses [Category] B형 간염,

[키워드] anti-HBV titer HBV reactivation hepatitis B Immunosuppression rituximab
[DOI] 10.3390/v14081780 PMC 바로가기

A case of ANCA-associated vasculitis in a 16-year-old female following SARS-COV-2 infection and a systematic review of the literature

SARS-COV-2 감염 후 16세 여성에서 발생한 ANCA 관련 혈관염 1예 및 체계적인 문헌 고찰

Case Reports

Published on 2022-08-132022-09-11
Journal: Pediatric Rheumatology Online Journal [Category] SARS, 바이오마커, 진단,

Persistent Fever and Positive PCR 90 Days Post-SARS-CoV-2 Infection in a Rituximab-Treated Patient: A Case of Late Antiviral Treatment

리툭시맙 치료 환자에서 SARS-CoV-2 감염 후 90일 동안 지속되는 발열 및 PCR 양성: 후기 항바이러스 치료 1례

Case Reports

Published on 2022-08-112022-09-11
Journal: Viruses [Category] SARS, 진단, 치료제,

[키워드] Antiviral treatment antivirals B cell B cell immune responses benefit Day defined diagnostic dominant Dyspnea early treatment feasible Fever full recovery high fever Hospitalized human long-term infection hyperinflammation Hypoxemia immune immune responses Immunocompromised Immunocompromised patients immunosuppressive immunosuppressive therapy infusion interval low-grade viral replication lower airway lower airways lung infiltrate lung infiltrates Mild mild to moderate moderate monoclonal monoclonal antibodies monoclonal antibody multiple sclerosis Patient patients PCR persistent persistent fever positive PCR test post infection Prophylactic receiving reduced reported Respiratory failure rituximab SARS-CoV-2 SARS-COV-2 infection sensitivity serum severe respiratory failure Symptom therapy Treatment treatment approach treatment approaches Viral viral replication
[DOI] 10.3390/v14081757 PMC 바로가기 [Article Type] Case Reports

Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies

B 세포 고갈 요법을받는 다발성 경화증 환자에서 COVID-19 예방 접종에 대한 강력한 T 세포 활성화

Article

Published on 2022-08-052022-09-11
Journal: Frontiers in Immunology [Category] SARS, 바이오마커, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adaptive Adaptive immune response Adaptive immunity analyzed anti-CD20 anti-CD20 therapy antibodies antibody production B-cell binding blocking activity BNT162b2 Cellular immune response cellular response Cohort competent Complication condition controls coronavirus COVID-19 COVID-19 vaccination depleting disease driven by form forms hACE2 healthy control humoral Humoral and cellular responses IFNγ IgG antibodies IgG antibody IL-2 immunocompromised individuals Immunotherapy implication individual individuals Infection investigation mRNA mRNA-1273 mRNA-based mRNA-based vaccine multiple sclerosis no difference Ocrelizumab Patient patients proliferation RBD receiving Receptor binding domain recognizing reduced regimen relapsing respiratory rituximab SARS-CoV-2 Seroconversion seroconversion rate severe acute respiratory syndrome Coronavirus significantly significantly higher Spike protein Strong strong T-cell susceptible T-cell T-cell activation T-cell Response therapy vaccination Vaccine design virus infection
[DOI] 10.3389/fimmu.2022.926318 PMC 바로가기 [Article Type] Article

Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses

강력한 CD8 T 세포 반응에도 불구하고 손상된 체액성 면역은 장기간의 COVID-19와 관련이 있습니다

Article

Published on 2022-07-112022-09-11
Journal: Cancer cell [Category] COVID19(2023년), SARS, 치료법,

[키워드] Affect Analysis analyzed antibody B cell B cells Cancer CD20 CD4 CD8 CD8 T cell cellular clearance convalescent COVID-19 COVID-19 infection Delayed demonstrated disease disease control dominant dysregulation effective exhibited functional highlight humoral immune response Humoral immunity immune dysregulation immune responses Impaired incidence increase in nucleocapsid Patient Patients with cancer Peripheral blood peripheral blood samples prolonged disease response rituximab robust SARS-CoV-2 SARS-CoV-2 clearance Spike protein Spike proteins T cell T cell memory T cell receptor T cell responses T cells TCR viral clearance
[DOI] 10.1016/j.ccell.2022.05.013 PMC 바로가기 [Article Type] Article

Successful use of casirivimab/imdevimab anti-spike monoclonal antibodies to enhance neutralizing antibodies in a woman on anti-CD20 treatment with refractory COVID-19

난치성 COVID-19를 가진 항-CD20 치료를 받는 여성의 중화 항체를 강화하기 위한 카시리비맙/임데비맙 항-스파이크 단일클론 항체의 성공적인 사용

Article

Published on 2022-07-012022-09-12
Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), SARS, 변종, 진단, 치료법,

Prolonged SARS-CoV-2 infection associated with long-term corticosteroid use in a patient with impaired B-cell immunity

B 세포 면역이 손상된 환자의 장기간 코르티코스테로이드 사용과 관련된 장기간의 SARS-CoV-2 감염

Case Reports

Published on 2022-07-012022-09-12
Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), SARS, 진단,

Prolonged shedding of infectious viruses with haplotype switches of SARS-CoV-2 in an immunocompromised patient

면역 저하 환자에서 SARS-CoV-2의 일배체형 스위치로 감염성 바이러스의 장기간 배출

Case Reports

Published on 2022-07-012022-09-11
Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술,

[키워드] accumulated acquired immunity Bendamustine Clinical course Complete Complete Remission convalescent stage COVID-19 COVID-19 case COVID-19 infection COVID-19 pneumonia detectable eight episode episode of follicular Follicular lymphoma Haplotype Host immune Immunity Immunocompromised Immunocompromised host Immunocompromised patient Infectious virus infectiousness Infectivity initial kinetic long-lasting lymphoma management mechanical ventilation Non-synonymous mutation Patient Pneumonia Prolonged raised required Respiratory failure rituximab SARS-CoV-2 SARS-CoV-2 variants spike gene suppressed tested the SARS-CoV-2 variants Viral Viral kinetic. Viral RNA
[DOI] 10.1016/j.jiac.2022.04.004 PMC 바로가기 [Article Type] Case Reports